SIHUAN Pharmaceuticals
subsidiary, Hainan Sihuan
Pharmaceutical, has signed a 30
year exclusive agreement with
Benxi Leilong Pharmaceutical to
distribute the latter’s Alprostadil
Injection to Sihuan
Pharmaceutical’s distribution
network of close to 10,000
hospitals in China.
The Alprostadil Injection is one
of the best-selling cardio-cerebral
vascular drugs in China and is an
intravenous injectable lipid emulsion
for treatment of peripheral
vascular diseases, cardio-cerebral
microcirculation disorders and
post-surgery thrombosis.The above article was sent to subscribers in Pharmacy Daily's issue from 19 Nov 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 19 Nov 10
DEMENTIA Australia has appointed comedian Geraldine Hickey (pictured) as its newest Ambassador, coinciding with the Melbourne Memory Walk & Jog event taking place this Sun.
NEW research from the Monash Addiction Research Centre has highlighted a critical shortfall in the availability of Naloxone, a life-saving medication that reverses opioid overdoses, across community pharmacies in Australia’s most populous states.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.